- Home
- ALUR vs MBRX Comparison
ALUR vs MBRX Comparison
Compare ALUR & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- MBRX
- Stock Information
- Founded
- ALUR 2009
- MBRX 2015
- Country
- ALUR United States
- MBRX United States
- Employees
- ALUR N/A
- MBRX N/A
- Industry
- ALUR
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ALUR
- MBRX Health Care
- Exchange
- ALUR Nasdaq
- MBRX Nasdaq
- Market Cap
- ALUR 21.1M
- MBRX 17.1M
- IPO Year
- ALUR N/A
- MBRX 2016
- Fundamental
- Price
- ALUR $2.40
- MBRX $0.68
- Analyst Decision
- ALUR Strong Buy
- MBRX Strong Buy
- Analyst Count
- ALUR 3
- MBRX 3
- Target Price
- ALUR $22.83
- MBRX $5.33
- AVG Volume (30 Days)
- ALUR 68.8K
- MBRX 2.6M
- Earning Date
- ALUR 08-13-2025
- MBRX 08-12-2025
- Dividend Yield
- ALUR N/A
- MBRX N/A
- EPS Growth
- ALUR N/A
- MBRX N/A
- EPS
- ALUR N/A
- MBRX N/A
- Revenue
- ALUR $28,304,000.00
- MBRX N/A
- Revenue This Year
- ALUR N/A
- MBRX N/A
- Revenue Next Year
- ALUR $49.37
- MBRX N/A
- P/E Ratio
- ALUR N/A
- MBRX N/A
- Revenue Growth
- ALUR N/A
- MBRX N/A
- 52 Week Low
- ALUR $2.15
- MBRX $0.25
- 52 Week High
- ALUR $22.25
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- ALUR 34.20
- MBRX 53.28
- Support Level
- ALUR $2.30
- MBRX $0.62
- Resistance Level
- ALUR $2.69
- MBRX $0.70
- Average True Range (ATR)
- ALUR 0.18
- MBRX 0.07
- MACD
- ALUR -0.06
- MBRX -0.00
- Stochastic Oscillator
- ALUR 14.29
- MBRX 61.43
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.